NCT04714372 2024-10-24FT538 in Combination With Daratumumab in AML Acute Myeloid LeukemiaMasonic Cancer Center, University of MinnesotaPhase 1 Completed9 enrolled 16 charts
NCT01849276 2019-01-31Metformin+Cytarabine for the Treatment of Relapsed/Refractory AMLNorthwestern UniversityPhase 1 Terminated2 enrolled 9 charts